Relief to Intas Pharmaceuticals: CESTAT directs Re-adjudication against Reversal of CENVAT Credit of Excise Duty on ground of Non-examination of actual date of Service Receipt [Read Order]

By Shabna Rahim - On November 4, 2023 5:50 pm - 2 mins read
Relief to Intas Pharmaceuticals - CESTAT - Re-adjudication - Reversal of CENVAT Credit - Excise Duty - Non-examination - Service Receipt - taxscan

The Ahmedabad bench of the Customs, Excise and Service Tax Appellate Tribunal (CESTAT) granted relief to Intas Pharmaceuticals by directing re-adjudication against the reversal of CENVAT credit of Excise duty on the ground of non-examination of the actual date of the service receipt.  Intas Pharmaceuticals Limited, the appellant assessee engaged in the manufacture of dutiable…

Your free access to Taxscan has Expired

To read the article, get a premium account.

Taxscan Premium

Why should you subscribe?
  • Enjoy our website without interruptions from advertisements
  • Receive Daily newsletters
  • Receive realtime Telegram/Whatsapp news updates
  • Download original Judgements / Order / Notifications / Circulars, etc
  • Enjoy exclusive entry fees to Simplified series. (Webinars, Seminars, masterclasses, etc.)
  ₹2299 + GST for 1 year

Subscribe Now

Already a member? Log in here

Topics

taxscan-loader